Literature DB >> 18313834

Co-expression of CYP27B1 enzyme with the 1.5kb CYP27B1 promoter-luciferase transgene in the mouse.

Paul H Anderson1, Ivanka Hendrix, Rebecca K Sawyer, Reza Zarrinkalam, Jim Manavis, Ghafar T Sarvestani, Brian K May, Howard A Morris.   

Abstract

The renal enzyme 25-hydroxyvitamin D 1alpha-hydroxylase (CYP27B1), responsible for the synthesis of circulating. 1,25-dihydroxyvitamin D (1,25D), is also expressed in a number of non-renal tissues. The regulation of CYP27B1 expression by the short flanking promoter outside the kidney is, however, largely unknown. We have used a transgenic mice expressing the 1.5kb promoter of the human CYP27B1 gene fused to the firefly luciferase gene in order to investigate tissue-specific CYP27B1 expression. These transgenic animals demonstrated co-localised luciferase and endogenous CYP27B1 expression in kidney proximal convoluted tubular cells. Strong co-expression of luciferase and CYP27B1 also occurred in neurons and Purkinje cells of the cerebellum and in Leydig and Sertoli cells of the testes. Other tissues to exhibit CYP27B1-promoter directed luciferase activity included lung, prostate, trabecular bone and jejunum as well as the choroid epithelium. The tissue specific changes in luciferase activity were age-related. These findings demonstrate that the proximal 1.5kb 5' flanking region of the CYP27B1 gene directs the expression of CYP27B1 in a number of known and novel tissues in a specific manner.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18313834     DOI: 10.1016/j.mce.2007.12.018

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  13 in total

Review 1.  Molecular mechanisms for regulation of intestinal calcium absorption by vitamin D and other factors.

Authors:  James C Fleet; Ryan D Schoch
Journal:  Crit Rev Clin Lab Sci       Date:  2010-08       Impact factor: 6.250

2.  Changes in osteocyte density correspond with changes in osteoblast and osteoclast activity in an osteoporotic sheep model.

Authors:  M R Zarrinkalam; A Mulaibrahimovic; G J Atkins; R J Moore
Journal:  Osteoporos Int       Date:  2011-05-31       Impact factor: 4.507

Review 3.  Vitamin D Activity and Metabolism in Bone.

Authors:  Paul H Anderson
Journal:  Curr Osteoporos Rep       Date:  2017-10       Impact factor: 5.096

4.  Autocrine and paracrine actions of vitamin d.

Authors:  Howard A Morris; Paul H Anderson
Journal:  Clin Biochem Rev       Date:  2010-11

5.  Purified mouse CYP27B1 can hydroxylate 20,23-dihydroxyvitamin D3, producing 1alpha,20,23-trihydroxyvitamin D3, which has altered biological activity.

Authors:  Edith K Y Tang; Wei Li; Zorica Janjetovic; Minh N Nguyen; Zhao Wang; Andrzej Slominski; Robert C Tuckey
Journal:  Drug Metab Dispos       Date:  2010-06-16       Impact factor: 3.922

6.  Mutation update and long-term outcome after treatment with active vitamin D3 in Chinese patients with pseudovitamin D-deficiency rickets (PDDR).

Authors:  Y Chi; J Sun; L Pang; R Jiajue; Y Jiang; O Wang; M Li; X Xing; Y Hu; X Zhou; X Meng; W Xia
Journal:  Osteoporos Int       Date:  2018-10-31       Impact factor: 4.507

7.  FGF-23 regulates CYP27B1 transcription in the kidney and in extra-renal tissues.

Authors:  Ankanee Chanakul; Martin Y H Zhang; Andrew Louw; Harvey J Armbrecht; Walter L Miller; Anthony A Portale; Farzana Perwad
Journal:  PLoS One       Date:  2013-09-03       Impact factor: 3.240

Review 8.  Vitamin D Actions on CD4(+) T Cells in Autoimmune Disease.

Authors:  Colleen Elizabeth Hayes; Shane L Hubler; Jerott R Moore; Lauren E Barta; Corinne E Praska; Faye E Nashold
Journal:  Front Immunol       Date:  2015-03-18       Impact factor: 7.561

9.  House dust mite induced lung inflammation does not alter circulating vitamin D levels.

Authors:  Ling Chen; Kara L Perks; Stephen M Stick; Anthony Kicic; Alexander N Larcombe; Graeme Zosky
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

Review 10.  The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control.

Authors:  F C Campbell; Haibo Xu; M El-Tanani; P Crowe; V Bingham
Journal:  Biochem Pharmacol       Date:  2009-09-06       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.